Dungan, Cory M <br/><br/>
Hyperactive mTORC1 signaling is unaffected by metformin treatment in aged skeletal muscle.  [electronic resource] 

 -  Muscle & nerve  Jan 2016 
 - 107-17 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-4598 
<br/><br/><label>Standard No.: </label>10.1002/mus.24698  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Age Factors<br/>Aging--drug effects<br/>Animals<br/>Exercise Test<br/>Histocompatibility Antigens Class I--metabolism<br/>Hypoglycemic Agents--pharmacology<br/>Male<br/>Mechanistic Target of Rapamycin Complex 1<br/>Metformin--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Multiprotein Complexes--metabolism<br/>Muscle, Skeletal--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--metabolism<br/>Transcription Factors--metabolism